A modeling study looked at how anticipated cuts to international HIV funding would affect the rate of new cases and ...

Working together with teams at Heidelberg and Yale Universities, they found that the enigmatic "spacer peptide 2," one of the virus components, plays a key role in converting immature HIV-1 ...

What about viruses? Would you consider them living or nonliving? Let’s look closely at the life cycle of the human immunodeficiency virus (HIV) – the virus that causes AIDS – to find out. This ...

Another important discovery was an intricate RNA structure near ... analysis revealed that while HIV-1 mRNAs are translated efficiently throughout infection, the virus suppresses the protein ...

HIV, the human immunodeficiency virus, is the microorganism responsible ... Some people have a genetic mutation that changes the shape of this protein, meaning HIV can no longer attach to their ...

An effective HIV-1 vaccine must therefore elicit antibodies that can neutralize many variants of the virus. While broadly neutralizing antibodies (bnAbs) have been isolated from HIV-1 infected ...

"We showed that these antibodies exist but what we don't yet know is how they shape ... HIV vaccine schedules, potentially ...

This molecule, known as EBC-46, works by temporarily activating the HIV virus in the affected cells as they hide so that the body’s immune system can remove the virus, according to a study published ...

Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication.